JacekPinskiMD

Oncology • Los Angeles, CA

Associate Professor, Medicine, USC School of Medicine

Join to view full profile

Dr. Pinski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pinski's full profile

Already have an account?

Office
1441 Eastlake Ave
Los Angeles, CA 90089
Phone+1 800-872-2273

Fax+1 323-865-0061
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
Ochsner Clinic FoundationResidency, Internal Medicine, 1996 - 1998
Goethe University Frankfurt Medical FacultyClass of 1988

Certifications & Licensure

CA State Medical License 2002 - 2026
MD State Medical License 1999 - 2001
American Board of Internal Medicine Medical Oncology

Clinical Trials

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer Start of enrollment: 2004 Jun 01
Completed
Phase 2
S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer
Withdrawn
Phase 2
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors Start of enrollment: 2006 Nov 01
Completed
Phase 1
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2007 Apr 01
Completed
Phase 2
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2010 Nov 02
Completed
Phase 1, Phase 2
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer Start of enrollment: 2006 Jun 01
Completed
Phase 2
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Start of enrollment: 2012 Jul 01
Terminated
Phase 2
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer Start of enrollment: 2016 Mar 01
Terminated
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer Start of enrollment: 2018 Aug 30
Withdrawn
Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures Start of enrollment: 2022 Mar 01
Recruiting
Not Applicable
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer Start of enrollment: 2015 Sep 08
Active, not recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

15 citations
Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate-sensitive prostate cancer (SWOG S1216)
Amir Goldkorn, Catherine M. Tangen, Melissa Plets, Gareth Morrison, Alexander Cunha, Tong Xu, Jacek Pinski, Sue A. Ingles, Timothy J. Triche, Andrea L. Harzstark, Mani...> ;Clinical Cancer Research. 2021 Jan 26
7 citations
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
Jacob Stephen Thomas, Anthony B. El-Khoueiry, Barry J. Maurer, Susan Groshen, Jacek Pinski, Everardo Cobos, David R. Gandara, Heinz Joseph Lenz, Min H. Kang, C. Patric...> ;Cancer Chemotherapy and Pharmacology. 2021 Jan 10
30 citations
Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
Mitchell E. Gross, David B. Agus, Tanya B. Dorff, Jacek Pinski, David I. Quinn, Olga O. Castellanos, Patrick O. Gilmore, Jean C. Shih> ;Prostate Cancer and Prostatic Diseases. 2021 Mar 1
6 citations
Expression of the luteinizing hormone receptor (LHR) in ovarian cancer
Shigang Xiong, Paulette Mhawech-Fauceglia, Denice D. Tsao-Wei, Lynda D. Roman, Rajesh K. Gaur, Alan L. Epstein, Jacek Pinski> ;BMC Cancer. 2019 Nov 15
4 citations
Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Afsaneh Barzi, Primo N. Lara, Denice D. Tsao-Wei, Dongyun Yang, Inderbir S. Gill, Siamak Daneshmand, Eric A. Klein, Jacek Pinski, David F. Penson, David I. Quinn, Sarm...> ;Cancer. 2019 Nov 1
9 citations
Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC).
Tanya B. Dorff, David I. Quinn, Jacek Pinski, Amir Goldkorn, Sarmad Sadeghi, Denice D. Tsao-Wei, Susan Groshen, Peter Kuhn, Mitchell E. Gross> ;Clinical Genitourinary Cancer. 2019 Aug 1
150 citations
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C. Danila, Bruce Montgomery, Christopher J. Hoimes, Russell Z. Szmulewitz, Ulka N. Vaishampayan, Andrew J. Armstrong, Mark N. ...> ;Clinical Cancer Research. 2019 Jan 1
40 citations
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.
Toshiyuki Ishiba, Andreas-Claudius Hoffmann, Joshua L. Usher, Yahya Elshimali, Todd Sturdevant, Mai Dang, Yolanda S Jaimes, Rama Tyagi, Ronald Gonzales, Mary Grino, Ja...> ;Biochemical and Biophysical Research Communications. 2018 Jun 7
6 citations
Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.
Tanya B. Dorff, Anne Schuckman, Rachel L. Schwartz, Sadaf Rashad, Ajaz Bulbul, Jie Cai, Jacek Pinski, Yanling Ma, Kathleen D. Danenberg, Eila C. Skinner, David I. Quinn> ;Clinical Genitourinary Cancer. 2016 Oct 1
13 citations
Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.
Ahva Shahabi, Juan Pablo Lewinger, Jie Ren, Craig April, Andy Sherrod, Joseph G. Hacia, Siamak Daneshmand, Inderbir S. Gill, Jacek Pinski, Jian-Bing Fan, Mariana C. Stern> ;The Prostate. 2016 Oct 1
7 citations
Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era.
Ahva Shahabi, Raj Satkunasivam, Inderbir S. Gill, Gary Lieskovsky, Sia Daneshmand, Jacek Pinski, Mariana C. Stern> ;Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada. 2016 Jan 14
27 citations
Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression
Nitin Patel, Tatsuo Itakura, Shinwu Jeong, Chun-Peng Liao, Pradip Roy-Burman, Ebrahim Zandi, Susan Groshen, Jacek Pinski, Gerhard A. Coetzee, Mitchell E. Gross, M. Eli...> ;Plos One. 2015 Feb 18
9 citations
A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer.
Tanya B. Dorff, Susan Groshen, Denice D. Tsao-Wei, Shigang Xiong, Mitchell E. Gross, Nicholas J. Vogelzang, David I. Quinn, Jacek Pinski> ;Prostate Cancer and Prostatic Diseases. 2014 Dec 1
14 citations
Effects of luteinizing hormone receptor signaling in prostate cancer cells.
Shigang Xiong, Qingcai Wang, Stephen V. Liu, Robert B. Montgomery, Frank Z. Stanczyk, John G. Vallone, Noah M. Merin, Jacek Pinski> ;The Prostate. 2015 Feb 1
27 citations
Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer
Stephen V. Liu, Denice D. Tsao-Wei, Shigang Xiong, Susan Groshen, Tanya B. Dorff, David I. Quinn, Yu-Chong Tai, Juergen Engel, Debra Hawes, Andrew V. Schally, Jacek Pi...> ;Clinical Cancer Research. 2014 Dec 15
24 citations
Differential Effects of RUNX2 on the Androgen Receptor in Prostate Cancer: Synergistic Stimulation of a Gene Set Exemplified by SNAI2 and Subsequent Invasiveness
Gillian H. Little, Sanjeev K. Baniwal, Helty Adisetiyo, Susan Groshen, Nyam-Osor Chimge, Sun Young Kim, Omar Khalid, Debra Hawes, Jeremy O. Jones, Jacek Pinski, Dustin...> ;Cancer Research. 2014 May 15
5 citations
Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.
Tanya B. Dorff, Denice D. Tsao-Wei, Susan Groshen, William D. Boswell, Amir Goldkorn, Shigang Xiong, David I. Quinn, Jacek Pinski> ;Clinical Genitourinary Cancer. 2013 Dec 1
8 citations
LHRH and LHR genotypes and prostate cancer incidence and survival
Sue A. Ingles, Stephen V. Liu, Jacek Pinski> ;International Journal of Molecular Epidemiology and Genetics. 2013 Nov 28
17 citations
Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases.
Alev Brown, Yanling Ma, Kathleen D. Danenberg, Anne Schuckman, Jacek Pinski, Lance C. Pagliaro, David I. Quinn, Tanya B. Dorff> ;Urology. 2014 Jan 1
Reply.
Brown, A.,Pinski, J. K.,Quinn, D. I.,Dorff, T. B.,Ma, Y.,Danenberg, K.,Schuckman, A. K.,Pagliaro, L. C.> ;Urology. 2013 Nov 19
90 citations
Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Jacek Pinski, David I. Quinn> ;Journal of Nuclear Medicine. 2013 Aug 1
94 citations
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Mitchell E. Gross, Jacek Pinski, David I. Quinn> ;Clinical Nuclear Medicine. 2012 Jul 1
70 citations
AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
J. Engel, Guenter Emons, Jacek Pinski, Andrew V. Schally> ;Expert Opinion on Investigational Drugs. 2012 May 11
9 citations
Immune response to sipuleucel-T in prostate cancer.
Eddie Thara, Tanya B. Dorff, Monica Averia-Suboc, Michael Luther, Mary Reed, Jacek Pinski, David I. Quinn> ;Cancers. 2012 Apr 18
15 citations
A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer.
Steven S. Yu, Kanthi Athreya, Stephen V. Liu, Andrew V. Schally, Denice D. Tsao-Wei, Susan Groshen, David I. Quinn, Tanya B. Dorff, Shigang Xiong, Jürgen Engel, Jacek ...> ;Clinical Genitourinary Cancer. 2012 Feb 10
Join now to see all

Press Mentions

USC Doctors Use Power of Poetry to Help Cancer Patients Heal: 'We Want This Movement to Spread'January 24th, 2022
Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of DirectorsJuly 9th, 2019
Presentation in Prostate Cancer at 2017 Genitourinary Cancers SymposiumMarch 6th, 2017